Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Post by ronrydellon Apr 30, 2015 9:40am

196 Views

Post# 23679893

Need some buyers over the short term

For all of your " true believers" we need some collective efforts in which shareholders pick up 500-1000 shares to get out of this "drip, drip, drip" activity since the big announcement of last Monday.

i wonder why we wouldn't at least stay in a holding pattern....the Chinese aren't that bad are they..after all money is very agnostic..Comments?

Bullboard Posts

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains